ALS patients were stratified according to disease progression rate to last visit (PRL: 48 minus the ALSFRS-R score at the last visit, divided per disease duration from onset in months) in slow (PRL < 0.5) and fast (PRL > 0.7). This evidence concerns the gene PRL and amyotrophic lateral sclerosis.